Gapping down
Select crypto related names showing early weakness:
- MSTR -5.8%, BITB -5%, GBTC -5%, BTCO -5%, IBIT -4.9%, BRRR -4.7%, BTCW -4.7%, DEFI -4.6%, HIVE -4.5%, COIN -3.5%
Other news:
- GTHX -53.2% (PRESERVE 2 did not achieve statistical significance in the primary endpoint; reaffirms guidance)
- RMD -10.8% (shares down 12% following Eli Lilly (LLY) tirzepatide trial results; Citigroup analyst says RMD"s trial assumptions might be "optimistic" based on this data)
- STOK -7% (discloses in SEC filing that its Chief Operating Officer and Chief Business Officer, Huw Nash Ph.D, has stepped down from position of Chief Operating Officer, effective immediately)
- HUT -5.3% (Coatue has agreed to invest $150 million into the Company through a convertible note)
- GOEV -3.7% (files for 13,719,850 share offering by selling shareholder; also files for 5,571,500 share offering by selling shareholder)
- KURA -3.2% (reported preclinical data supporting the potential therapeutic utility of menin inhibitors in the treatment of diabetes)
- TNDM -3% (Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions)
- SON -2.9% (acquire Eviosys for ~$3.9 bln)
- LBRDA -2.2% (announces proposed private offering of exchangeable senior debentures)
- UAA -2% (announces agreement to settle class action litigation)
- SBS -2% (files for ADS offering)
- HCM -1.9% (European Commission Approval for FRUZAQLA (fruquintinib) Received by Takeda)
- AMC -1.3% (in discussions to lower its debt load, according to Bloomberg)
- ITI -1.2% (files for $150 mln mixed securities shelf offering)
- CRNX -1.2% (files mixed securities shelf offering; also files for common stock offering by selling shareholders)